Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $359.22 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $202.80 | 8 | $0 (2024) |
| Novo Nordisk Inc | $125.00 | 1 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $31.42 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $86.69 | 4 | PFIZER INC. ($86.69) |
| 2023 | $44.09 | 2 | PFIZER INC. ($44.09) |
| 2022 | $103.44 | 3 | PFIZER INC. ($72.02) |
| 2021 | $125.00 | 1 | Novo Nordisk Inc ($125.00) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/01/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/21/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/05/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/11/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/28/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/01/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $31.42 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/11/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $39.18 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/28/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $32.84 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/11/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 113 | 261 | $68,286 | $15,342 |
| 2022 | 3 | 144 | 346 | $103,469 | $20,932 |
| 2021 | 2 | 53 | 172 | $68,464 | $14,215 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 95 | 231 | $63,756 | $14,167 | 22.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 18 | 30 | $4,530 | $1,175 | 25.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 99 | 282 | $77,833 | $15,693 | 20.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 26 | 45 | $17,865 | $3,657 | 20.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 19 | 19 | $7,771 | $1,582 | 20.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 38 | 157 | $62,329 | $12,938 | 20.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 15 | 15 | $6,135 | $1,276 | 20.8% |
About Marie Abate, PA-C
Marie Abate, PA-C is a Physician Assistant healthcare provider based in Valhalla, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/29/2021. The National Provider Identifier (NPI) number assigned to this provider is 1285225524.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Marie Abate, PA-C has received a total of $359.22 in payments from pharmaceutical and medical device companies, with $86.69 received in 2024. These payments were reported across 10 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($359.22).
As a Medicare-enrolled provider, Abate has provided services to 310 Medicare beneficiaries, totaling 779 services with total Medicare billing of $50,489. Data is available for 3 years (2021–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Valhalla, NY
- Active Since 01/29/2021
- Last Updated 01/29/2021
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1285225524
Products in Payments
- ELIQUIS (Drug) $202.80
- RYBELSUS (Drug) $125.00
- XARELTO (Drug) $31.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Valhalla
Amna Rauf
Physician Assistant — Payments: $2,319
Mr. Luis Munoz, Physician Assistant, PHYSICIAN ASSISTANT
Physician Assistant — Payments: $2,002
Brooke Terracino
Physician Assistant — Payments: $1,204
Anthony Boccasini, Pa, PA
Physician Assistant — Payments: $961.01
Mrs. Nicole Richardson, Pa, PA
Physician Assistant — Payments: $698.31
Mrs. Erica Bernardini, Pa-C, PA-C
Physician Assistant — Payments: $607.73